RECURSION PHARMACEUTICALS, INC. (NASDAQ: RXRX) is a biotechnology company. The company revised its agreement with Tempus AI, Inc. (NASDAQ: TEM) replacing the previous annual-fee structure with $14,000,000 payments for each of the third, fourth and fifth anniversaries of the effective date.
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a Pharmaceuticals: Other company. Its American Depositary Shares have regained compliance with Nasdaq’s $1.00 minimum bid-price requirement, and Nasdaq has closed the matter.
The amount includes $150.0 million issued under the underwriters’ fully exercised over-allotment option. The notes do not pay regular interest or increase in principal, and mature on September 15, 2031, unless converted, redeemed or repurchased earlier.
ASTRAZENECA PLC (NYSE: AZN) is a Pharmaceuticals: Major company. Klygefa (gefurulimab) has received a positive recommendation for European Union approval in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis. The proposed use is as an add-on to standard therapy.
ASTRAZENECA PLC (NYSE: AZN) is a major pharmaceuticals company. Enhertu has received a positive recommendation in theEuropean Unionfor adults with residual invasive HER2-positive early breast cancer after neoadjuvant treatment, with DESTINY-Breast05 showing a 53% reduction in invasive disease recurrence or death versus T-DM1. The …
Management will participate in a Nomura investor meeting in Hyderabad on 25.09.2026, with the in-person session set for 11:00 to 14:00 IST.
MindWalk Holdings Corp. (NASDAQ: HYFT) is a biotechnology company. The company has moved the open-source OpenFold3 structure-prediction model into a production deployment using AMD and Vultr infrastructure, testing the complete workflow inside its discovery operations.
Nuran Wireless Inc. (NASDAQ: NUR) is an electronics distributor. Its amended and restated Annual Information Form is dated June 4, 2026, while the information covered is current as of December 31, 2025.
PETMED EXPRESS expanded its board to 5 directors by appointing Tamar Elkeles as an independent director effective September 17, 2026. Investors gain a board member assigned to compensation, human capital, governance and nominating committees, with the company citing her executive, advisory and board experience …
Cayman Petition and U.S. Securities Case